liver. These are often erroneously called "false-positive" tests, implying that the tests have given the wrong result, rather than that they have been interpreted incorrectly. It must be emphasized, therefore, that function tests have their limitations, and that it is quite impossible to interpret them without an understanding of what they measure.
Several features of the liver make it a peculiarly difficult organ to study functionally. Among these may be mentioned: one, the multiplicity of its functions, not all of which are equally or simultaneously affected in disease; two, its tremendous reserve and regenerative power, which permit extensive damage or removal of tissue before any of its functions are disturbed; and, three, the intimate anatomical relationships of its glandular, excretory, and vascular components, which make for complex functional disturbances, even when the initial injury is confined to one component. It is not difficult to understand, then, why early attempts to find a single comprehensive test of liver function were bound to fail. The recent trend has been toward the use of a battery of tests,41 varying in sensitivity and measuring a variety of functions, usually performed simultaneously, and often serially. While this approach has added very materially to our understanding of liver disease, it has also led to considerable confusion. Unfortunately, as the number and sensitivity of the tests increase, they become increasingly difficult to interpret.
In general, function tests are called upon to answer one of three questions: (1) Is liver disease present? (2) What is the nature of the disease? (3) What course is established liver disease taking?
Usually the first question, regarding the presence of liver disease, is raised when jaundice is absent and when hepatomegaly or splenomegaly is found, when there is a history of exposure to known or suspected hepatotoxins, or when the symptoms suggest the onset of infectious hepatitis. As a rule this question can be answered satisfactorily by function tests.
The second question, regarding the nature of the disease, can rarely be answered by function tests when jaundice is absent, since none of the tests now available can distinguish the many known types of parenchymal damage. Here, the diagnosis must rest on other clinical and laboratory data. In the presence of jaundice, on the other hand, the tests may be very helpful. As a rule, however, they are confirmatory here rather than diagnostic. The distinction between hemolytic and hepatic jaundice can be made with reasonable accuracy. The differentiation of the jaundice due to parenchymal damage and that due to obstruction of the biliary tree, however, is a much more difficult prob- While it is generally agreed that several function tests are required for the adequate study of liver disease, there is no uniformity of opinion about which of the tests serve this purpose best. Those discussed below have been in use for several years at the Yale University School of Medicine. With the exception of the serum lipids and proteins, the tests have been performed simultaneously and usually serially. Those chosen appear to provide about as much useful information as can be reasonably expected from this method of study. Moreover, the required blood and excreta collections are relatively simple to carry out on the wards or in the out-patient clinic, and the technical methods employed in analyzing them are reliable and can be carried out in any well-equipped clinical laboratory. No doubt there are other tests equally good, but we have not used them, either because they are technically difficult or too timeconsuming, or because they do not appear to add any information to that obtainable with the tests now in use.
Serum bilirubin
The level of the serum bilirubin is dependent on two factors: the rate of bilirubin production from hemoglobin in the reticulo-endothelial system and the rate of bilirubin excretion through the biliary tract. A rise in serum bilirubin may, therefore, be due to: (1) excessive hemol-ysis resulting in increased bilirubin production, (2) The concept that the prompt, direct-reacting bilirubin has traversed the liver cells and has been regurgitated is an assumption that still awaits proof. In any event, the qualitative van den Bergh reaction has proved to be of no value in differentiating obstructive from hepatocellular jaundice. Moreover, by sensitive quantitative methods it has been possible to demonstrate both "types" of bilirubin not only in the sera of both obstructive and hepatocellular jaundice, but also in the sera of normal individuals. 45 Recently There are a number of simple tests for detecting the presence of bilirubin in urine. Since bilirubinuria may occur with relatively slight increases in serum bilirubin, the tests are often of value in recognizing jaundice early, as in infectious hepatitis or in recent biliary obstruction, and in following the course of jaundice, especially when it is fading. While the presence of bilirubin in urine differentiates hepatic from hemolytic jaundice, it cannot be used to distinguish obstructive from parenchymatous jaundice.
Urine urobilinogen
The bilirubin excreted into the intestinal tract is converted to urobilinogen by bacterial action, and is returned to the liver by way of the portal blood. Normally, the liver removes most of this urobilinogen and only a small fraction is excreted in the urine. Urine urobilinogen is increased when the liver fails to clear the blood of urobilinogen. This may occur when there is liver damage, as in hepatitis or cirrhosis, or when the normal capacity of the liver to remove urobilinogen is exceeded by its production, as in hemolytic jaundice. Rich28 does not believe that the increased bilirubin and urobilinogen production in hemolytic jaundice can exceed the excretory capacity of the normal liver, and he assumes, therefore, that liver damage, probably due to anemia, must be present to account for the increase in urine urobilinogen.
The excretion of urobilinogen is a sensitive index of hepatic function, but normal values may be misleading unless quantitative determinations are carried out serially, preferably on 24-hour collections, and unless the state of the feces is known. Urobilinogen excretion fluctuates over a wide range throughout the day, and from day to day, both in normal persons and in subjects with liver disease. Moreover, when bilirubin fails to reach the intestinal tract, due either to biliary obstruction or to failure of the liver to excrete bile, no urobilinogen is produced and urobilinogenuria cannot occur, even if considerable parenchymal damage is present. This is well illustrated in infectious hepatitis. Early in the disease there is an increased excretion of urobilinogen. Later, as the injury increases and bile excretion is sup-pressed, the stools become clay colored and urobilinogen disappears from the urine. During convalescence, as bile excretion is resumed, the stools return to their normal color, and urobilinogen reappears in the urine. Finally, the urobilinogen level falls to normal when complete recovery has occurred.
Simple quantitative tests for urobilinogen are useful in establishing the presence of liver damage and in following its progress, especially in the absence of jaundice and when more elaborate tests are not available. When jaundice is present tests may occasionally be of value in differentiating hemolytic from hepatic jaundice and in estimating the degree of biliary obstruction or suppression present. In interpreting these tests, however, it must be recognized that increased urobilinogen excretion may occur in a number of diseases in which the liver is not primarily affected, such as in severe streptococcal and pneumococcal infections, and in malaria.
Fecal urobilinogen The urobilinogen that escapes reabsorption in the intestine is oxidized to urobilin and stercobilin which impart a brown color to the feces. When bilirubin fails to reach the intestine or is decreased in amount, due either to biliary obstruction or to failure of the liver to excrete it, the fecal urobilinogen falls and the feces become clay colored. Quantitative determination in these cases, however, usually reveals the presence of small but significant amounts of urobilinogen, indicating that biliary obstruction is rarely complete. When Bromsulphalein excretion It is generally assumed that bromsulphalein is removed from blood almost exclusively by the liver.3 Recent experiments, however, indicate that as much as one-quarter of the injected dye may be removed in the absence of the liver, gastro-intestinal tract, and kidneys.6 Moreover, the dye disappears from the blood more rapidily than it is excreted in the bile,44 and blockade of the reticulo-endothelial system results in dye 18, 24 retention, suggesting that the reticulo-endothelium plays an inportant role in bromsulphalein excretion. Nevertheless, the rate at which this dye is cleared from blood has proved to be a sensitive index of hepatic parenchymal function.
In the absence of jaundice the degree of dye retention is usually proportional to the extent of parenchymal damage present. Since the dye is excreted via the biliary tree, retention will also occur with biliary obstruction. Moreover, an increase in serum bilirubin may in itself produce dye retention.9 Therefore, the test is difficult to interpret in the face of jaundice. In general, dye retention parallels the height of the serum bilirubin in uncomplicated biliary obstruction, and is disproportionately higher when parenchymal damage is present. However, the variations in both dye and bilirubin retention are so great that the ratio between the two cannot be relied upon as an index of parenchymal function in the presence of jaundice.
The bromsulphalein test has its greatest value in establishing the presence of liver disease, and in following its course, when jaundice is absent. As with the other tests, it is of no aid in determining the nature of the lesion. Moreover, it has the disadvantage of being sufficiently sensitive to detect minor degrees of impaired hepatic function incidental to other diseases, such as pneumonia, anemia, and congestive heart failure, so that these may be mistaken for primary liver disease.
Alkaline phosphatase The serum alkaline phosphatase level is frequently elevated in liver disease, especially in the presence of jaundice. The mechanism responsible for this increase is not fully understood. The enzyme occurs in a great many tissues, including the liver, the bones, and the intestinal mucosa, and is normally excreted in the bile. According to a commonly held view the increase in serum phosphatase is a retention phenomenon, the result of decreased hepatic excretion, due either to parenchymal damage or to biliary obstruction.30 36 While this mechanism may account for the rise in serum phosphatase in extrahepatic biliary obstruction, it can hardly be the basis for the rise which occurs in biliary fistula, nor can it account for the relatively normal phosphatase values reported in congenital atresia of the bile ducts.4' Drill's work on experimental biliary fistula suggests that retention of phosphatase in blood may be due not only to a failure of biliary excretion, but also to an over-production of the enzyme by the liver which exceeds the excretory capacity of that organ."0 Thannhauser's experiments suggest still another possible explanation-that the apparent elevation of the serum phosphatase level may not be due to an actual increase in concentration, but rather to an increase in enzyme activity resulting from other chemical alterations in the blood. 34 Unfortunately not all workers have been able to confirm these interesting observations.8
The alkaline phosphatase level is of relatively little significance in the diagnosis of liver disease unaccompanied by jaundice. It is of very real value, however, in the differential diagnosis of jaundice. The level is usually normal in hemolytic icterus, slightly elevated in hepatocellular, and greatly elevated in obstructive jaundice. Occasionally the serum phosphatase level rises significantly in the absence of jaundice. This is said to occur especially in some cases of cirrhosis and in metastatic carcinoma of the liver. 11 There is a small group of cases with chronic jaundice, due primarily to hepatocellular disease, in which the serum alkaline phosphatase is often as greatly increased as in extrahepatic biliary obstruction. This group includes what Watson calls "cholangiolitic hepatitis and cirrhosis,"40 some forms of arsenical hepatitis,1 14 many cases of biliary cirrhosis, and an occasional case of Laennec's cirrhosis. It is usually assumed that the jaundice in these cases is due to intrahepatic biliary obstruction or injury to the terminal branches of the biliary tree resulting in regurgitation of bile into the blood. The evidence for this assumption is by no means convincing, but whatever the mechanism, it is an unfortunate fact that none of the tests of hepatic function can be relied upon to distinguish this type of jaundice from that of extrahepatic biliary obstruction. The diagnosis in this group usually depends almost entirely on the history and physical findings, and often cannot be established with certainty until the liver and biliary tree have been explored surgically.
From a practical point of view, values above 12 Bodansky units usually indicate obstructive, and those between 5 and 10 units, hepatocellular jaundice. Except in the group just mentioned, there have been surprisingly few deviations from this rule of thumb in our series. In the few instances in which the phosphatase has failed to rise to the expected level in obstructive jaundice, there has usually, although not always, been evidence to suggest that the obstruction was relieved and that the jaundice was fading.
It is important to study the serum phosphatase serially during the development of jaundice, since initial values may be misleading. Quite often the alkaline phosphatase is only slightly elevated shortly after the onset of obstruction, but as the jaundice deepens the usual sharp increase can be demonstrated. Early in infectious hepatitis, on the other hand, values as high as 10 and 12 units may be found, but they do not increase as the jaundice deepens, and they usually fall.
The serum alkaline phosphatase may also rise in a variety of bone diseases, such as Paget's disease and hyperparathyroidism, so that these must be kept in mind, especially when the elevation is unaccompanied by other signs of liver damage.
Serum proteins
The liver plays an important r6le in both the synthesis and storage of proteins, which is reflected in the qualitative and quantitative composition of the serum proteins. In hepatocellular disease there is a tendency for the albumin fraction to fall and the globulin fraction to rise. While the decrease in serum albumin is clearly correlated with hepatocellular injury, the significance of the rise in globulin is not yet fully understood. There is evidence to indicate that the globulins are largely extra-hepatic in origin, some arising in the lymphocytes, others in the reticulo-endothelial system. The liver may, therefore, play a role in globulin synthesis through its reticulo-endothelial component, the Kupffer-cell system.43 Recent studies on the behavior of the globulins in infectious hepatitis, suggest that globulin changes may be related to inflammatory5 and regenerative20 processes in the liver rather than to degenerative changes in the parenchymal cells.
In moderately severe liver injury the total serum protein falls, almost exclusively at the expense of the albumin fraction. With less severe injury the total proteins may remain at a normal level, despite a decrease in albumin, because of an increase in the globulin fraction. Finally, in some forms of chronic hepatitis'5 the increase in globulin may be so great that the total serum protein level is raised above normal.
An analysis of the serum protein and its constituents is of the greatest importance in studying the state of the liver. In the differential diagnosis of jaundice, the finding of a decreased serum albumin, or of an increased globulin, favors an hepatocellular etiology. In general, the serum proteins are little changed in obstructive jaundice, except when this has been present for a relatively long time, and has been complicated by secondary parenchymal damage. Unfortunately, the serum proteins are often misleading in that difficult group, already mentioned, of "cholangiolitic" hepatitis and biliary cirrhosis, in which the clinical and laboratory findings suggest extrahepatic obstructive jaundice. While the primary fault in these cases lies in a parenchymal lesion, the serum proteins are often normal.
The serum proteins often return to normal long before many other abnormalities of hepatic function, so that the former cannot be relied upon to determine when complete recovery from injury has occurred, as, for example, in infectious hepatitis. Moreover, many cases of frank liver disease never develop gross changes in serum albumin or globulin. Finally, caution must be used in interpreting serum protein values. First, fractionation of the serum proteins is not a simple technique and is subject to technical errors. Secondly, the composition of the serum proteins is altered in a great many other diseases, and, lastly, it is in-13)7 fluenced by the dietary intake, an especially important factor in chronic liver disease.
Cephalin-cholesterol flocculation and thymol turbidity tests The serum globulins can be fractionated by salting-out methods or by electrophoresis. In liver disease, and in a wide variety of acute and chronic infections, parasitic infestations, and tumors, there is often a selective increase in the individual fractions, with or without an increase in the total globulins. Since the usual globulin fractionation methods are too difficult and time-consuming for routine clinical use, a number of relatively simple, although admittedly crude, tests have been devised to measure these changes. Among these are the cephalin-cholesterol flocculation and the thymol turbidity tests, which have proved to be of some value in the diagnosis of liver disease. It is self-evident that both must be interpreted with caution, since they may be positive in any disease which alters the serum globulin pattern. This is especially true of the cephalin-cholesterol flocculation test.
Although the results of the two tests are in agreement in many types of liver disease,42 there are often striking discrepancies, based, no doubt, on differences in the mechanism of the two reactions.
The cephalin-cholesterol flocculation test appears to depend primarily on an increase in gamma globulin, but is also influenced, to some extent, by a reduction or qualitative change in serum albumin.23 The thymol turbidity reaction is less well understood. According to Cohen and Thompson' it can be correlated with the serum beta globulin level. Kunkel, 19 on the other hand, believes that the apparent changes in beta globulin demonstrated electrophoretically depend mainly on the serum lipid level, and are not due to alterations in the serum protein pattern. He and others22' 27 have found that elevated thymol turbidity values in liver disease are usually closely related to increases in gamma globulin, and that the serum lipids play an important role in the reaction.
Both tests are of value in the diagnosis of liver disease, and are thought to indicate hepatocellular injury. The cephalin flocculation test is usually positive in cirrhosis and hepatitis, and is frequently positive in other diffuse hepatic lesions. The thymol turbidity test, on the other hand, is usually positive in hepatitis, but is often negative or only weakly positive in cirrhosis. Watson39 finds that the thymol turbidity test is much more frequently positive in the cirrhosis that follows hepatitis than it is in Laennec's cirrhosis, and suggests that it may be of value in differentiating the two. Experience in this laboratory appears to confirm this observation.
The tests are often useful in the differential diagnosis of jaundice. When positive they suggest an hepatocellular etiology. However, they may also become positive in obstructive jaundice especially when of long duration, or complicated by biliary infection. A strongly positive thymol turbidity test is highly suggestive of some form of hepatitis and is rarely seen in cirrhosis or obstructive jaundice. Recently Neefe 6 has reported that a 24-hour reading of thymol flocculation may be more sensitive than the turbidity test, and, indeed, may be the only sign of chronic hepatitis. Others29 have come to essentially the same conclusion. In this laboratory, however, significant flocculation has invariably been accompanied by an increase in turbidity, so that this modification of the original thymol test has been of no value.
Prothrombin level
The plasma prothrombin level may be lowered by liver disease in one of two ways. There may be a failure of vitamin K absorption due to lack of bile salts in the intestinal tract, or there may be a defect in prothrombin synthesis due to hepatocellular damage.
The prothrombin level is of little value in the diagnosis of liver disease without jaundice, since it is a relatively insensitive test of hepatic function. The response of a decreased prothrombin level to the parenteral administration of vitamin K has been advocated as a test of liver function35 and as a means of differentiating hepatocellular from obstructive jaundice.12 In this clinic it has proved to be unreliable, in that a good response has not always excluded parenchymal damage. The prothrombin level is worth studying, however, for its prognostic value. A low level which fails to respond to parenteral vitamin K in large doses can be taken as a sign of severe liver damage, whether jaundice is present or not, and it, if persistent, usually indicates a poor prognosis.
Serum lipids
The liver is an important factor in lipid metabolism, and disturbances in that organ frequently result in alterations of the serum lipid pattern. The most striking changes are to be seen in the cholesterol fraction, but the more subtle changes which occur in the other fractions of the serum lipids, and especially in the phospholipids, may be of equal importance.23
The level of the total serum cholesterol tends to rise when there is biliary obstruction, although this is, by no means, a constant finding. In a general way the degree of hypercholesteremia can be correlated with the extent and duration of the obstruction. However, hypercholesteremia may also occur with parenchymatous liver disease, especially in those cases of hepatitis and cirrhosis with clinical features suggesting intrahepatic obstructive jaundice.
The serum cholesterol level falls when there is extensive parenchymal damage. In the vast majority of patients with parenchymatous liver disease, however, the total serum cholesterol remains within normal limits.
The cause for the increase in serum cholesterol in liver disease is not known. The view that it is due to simple retention33 is open to serious question. It is based on the assumption that cholesterol is excreted chiefly by the liver, and that suppression of bile, either by parenchymal damage or by obstruction, results in cholesterol retention in the blood. Experimental evidence, however, suggests that the intestinal mucosa, rather than the liver, is the principal site of cholesterol excretion.32 Moreover, the observation that hypercholesteremia often occurs with biliary fistula cannot be explained on the basis of retention, and suggests another mechanism.
Cholesterol occurs in both free and esterified forms in the serum. In the absence of liver disease the ratio of the two remains remarkably constant within narrow limits, irrespective of the total cholesterol concentration. In all forms of liver disease, however, whether due to biliary obstruction or to parenchymal damage, there is a tendency for the esterified fraction to fall.23 It is difficult to account for this relative decrease in the esters. It cannot be due solely to a failure of esterification in the liver, since the absolute values for cholesterol esters are often above normal in cases of liver disease associated with hypercholesteremia.
Compared to some of the other tests of liver function, the serum cholesterol pattern is relatively insensitive, so that it is not of much value in the diagnosis of subclinical liver disease, although it may be confirmatory in some cases. Even in cases with overt liver disease the total cholesterol and the ratio of the cholesterol esters are often within normal limits.
The total cholesterol level is occasionally of value in the differential diagnosis of jaundice. On the whole, high concentrations point to biliary obstruction, and low values to parenchymal disease. Unfortunately, the cholesterol level may be quite normal in recent obstruction, and may be significantly elevated in some forms of parenchymatous liver disease, especially in that difficult group, already mentioned several times, in which the clinical* features simulate extrahepatic biliary obstruction. Low values for total cholesterol, on the other hand, almost always indicate severe parenchymal damage and may be regarded as a sign of poor prognosis.
While the ratio of cholesterol esters may be decreased in both obstructive and parenchymatous jaundice, it may at times, nevertheless be of value in differential diagnosis. In general, the ester ratio is not decreased significantly in obstructive jaundice unless hypercholesteremia is present, so that a low ester ratio usually suggests parenchymal damage when the total serum cholesterol level is normal. The decrease in the ester ratio in prolonged obstructive jaundice with hypercholesteremia may also be due to superimposed parenchymatous damage. 33 Repeated cholesterol studies are of some value in following the course of liver disease, but, on the whole, the procedure is technically so much more difficult than that of many other equally good tests, that it cannot be recommended for routine use. A decline in the proportion of esters usually denotes progressive parenchymal damage. In biliary obstruction with initial hypercholesteremia, a decrease in the total cholesterol concentration may indicate either a resumption of normal biliary flow or the development of parenchymal damage, but when it falls significantly below the normal level it always indicates extensive parenchymal damage and a poor prognosis.
The concentration of the serum phospholipids tends to parallel that of the total cholesterol in liver disease. Man and her associates23 stress the importance of an increase in the phospholipid:cholesterol ratio, especially in those conditions associated with hypercholesteremia. The concentration of neutral fat in the serum of patients with liver disease is usually normal, although it may be increased in biliary obstruction and in severe infectious hepatitis. 23 The significance of these observations is not yet fully understood, and while fractionation of all the serum lipids may add to our knowledge of fundamental disturbances in the liver, it cannot be recommended as a routine test of liver function. Conclusions 1. Liver function tests have their greatest value in the diagnosis of subclinical liver disease and in following the course of overt liver disease.
2. They are of far less value than are the history, physical examination, and other clinical data, in the differential diagnosis of outspoken disease, and are, at best, confirmatory.
3. The tests are of greatest value to the clinician who understands their mechanisms and limitations and who keeps clearly in mind his objectives in doing the tests.
